Avidity Biosciences, Inc. short interest in 2022
In 2022, Avidity Biosciences, Inc.'s disclosed short interest ran from 8.04% of shares outstanding on 14 Jan 2022 to 15.20% on 30 Dec 2022, a change of +7.16 percentage points. The year's high was 15.20% on 30 Dec 2022 and its low 7.72% on 31 Jan 2022, averaging 9.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.17 days on 29 Jul 2022. Full history: Avidity Biosciences, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 8.04% (14 Jan 2022)
- End of year
- 15.20% (30 Dec 2022)
- Change
- +7.16 pp
- High
- 15.20% (30 Dec 2022)
- Low
- 7.72% (31 Jan 2022)
- Average
- 9.99%
- Highest days to cover
- 25.17 (29 Jul 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 8.04% | 16.69 | |
| 31 Jan 2022 | 7.72% | 12.07 | |
| 15 Feb 2022 | 7.96% | 15.95 | |
| 28 Feb 2022 | 8.11% | 8.14 | |
| 15 Mar 2022 | 8.28% | 19.41 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 8.39% | 19.10 | |
| 14 Apr 2022 | 8.37% | 19.04 | |
| 29 Apr 2022 | 8.25% | 21.48 | |
| 13 May 2022 | 8.63% | 15.21 | 10-Q filed, results (8-K) |
| 31 May 2022 | 9.45% | 13.40 | |
| 15 Jun 2022 | 9.90% | 18.81 | |
| 30 Jun 2022 | 11.40% | 7.23 | |
| 15 Jul 2022 | 11.85% | 24.39 | |
| 29 Jul 2022 | 11.18% | 25.17 | |
| 15 Aug 2022 | 10.68% | 16.52 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 10.10% | 20.73 | |
| 15 Sep 2022 | 10.16% | 15.71 | |
| 30 Sep 2022 | 8.80% | 5.76 | |
| 14 Oct 2022 | 9.45% | 13.31 | |
| 31 Oct 2022 | 10.20% | 8.16 | |
| 15 Nov 2022 | 12.91% | 16.14 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 12.88% | 10.52 | |
| 15 Dec 2022 | 11.95% | 1.10 | |
| 30 Dec 2022 | 15.20% | 2.93 |
See also: Avidity Biosciences, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.